Speaker
Mr
Martin Grashei
(Department of Nuclear Medicine, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany)
| preferred presentation format | oral |
|---|
Primary author
Mr
Martin Grashei
(Department of Nuclear Medicine, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany)
Co-authors
Mr
Pascal Wodtke
(Department of Nuclear Medicine, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany)
Dr
Jason G. Skinner
(Department of Nuclear Medicine, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany)
Ms
Sandra Sühnel
(Department of Nuclear Medicine, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany)
Ms
Nadine Setzer
(Department of Nuclear Medicine, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany)
Mr
Thomas Metzler
(Comparative Experimental Pathology (CEP), Institute of Pathology, School of Medicine, Technical University of Munich, Munich, Germany)
Dr
Sebastian Gulde
(Institute for Diabetes and Cancer, Helmholtz Zentrum München, Neuherberg, Germany)
Ms
Mihyun Park
(Department of Biosciences, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany)
Ms
Daniela Witt
(Department of Biosciences, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany)
Dr
Hermine Mohr
(Institute for Diabetes and Cancer, Helmholtz Zentrum München, Neuherberg, Germany)
Dr
Christian Hundshammer
(Department of Nuclear Medicine, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany)
Prof.
Nicole Strittmatter
(Department of Biosciences, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany)
Prof.
Natalia S. Pellegata
(Institute for Diabetes and Cancer, Helmholtz Zentrum München, Neuherberg, Germany)
Dr
Katja Steiger
(Comparative Experimental Pathology (CEP), Institute of Pathology, School of Medicine, Technical University of Munich, Munich, Germany)
Prof.
Franz Schilling
(Department of Nuclear Medicine, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany)
